Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
about
Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapyCancer trials in sub-Saharan Africa: Aligning research and care.A comparative investigation of methods for longitudinal data with limits of detection through a case study.Epidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings.Meeting the challenge of hematologic malignancies in sub-Saharan AfricaIs cytotoxic chemotherapy for lymphoma currently feasible for patients in Malawi? A debate.CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi.Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology.Treatment outcomes in AIDS-related diffuse large B-cell lymphoma in the setting roll out of combination antiretroviral therapy in South AfricaAIDS-Related Non-Hodgkin's Lymphoma in Sub-Saharan Africa: Current Status and Realities of Therapeutic ApproachHIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities.Risk factors for common cancers among patients at Kamuzu Central Hospital in Lilongwe, Malawi: A retrospective cohort studyLymphoma and Pathology in Sub-Saharan Africa: Current Approaches and Future Directions.The oncology pharmacy in cancer care delivery in a resource-constrained setting in western Kenya.
P2860
Q28541831-23A88F19-4109-4AED-B9C1-80AC10A10490Q33887891-055820F7-AF9B-4152-A853-B402A5E5D19FQ34232733-DD21FF2D-500E-4981-A2A9-746715B1624AQ34637897-1647135F-61D2-42C1-A154-9C4A769F29C6Q35865085-E09E49C0-C75F-4A0A-BD2B-620F70378A72Q35938319-FCA60E7F-8087-4A38-800E-D1C39B1D1990Q35942794-11EC75D6-61BA-4725-AA08-EBEE1CF96103Q35975850-B61D49E7-8BC7-4194-8AB6-E943C202239AQ37231689-4BEA892A-2A81-414F-8350-66B7F5A625D1Q37280653-EAE77428-B4A5-4F81-88CA-86CB9AAC1614Q38944679-1429A0E6-E234-40AD-8EFA-06A2AB21A4B0Q41686395-E18A8F54-25A5-4423-8E35-1D708787505AQ50140468-D21B730C-689A-450C-845C-C5AA6935AFADQ51450121-B8CF6016-3395-4A2C-B0EF-FDC8715A7D98
P2860
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dose-modified oral chemotherap ...... kin's lymphoma in East Africa.
@en
Dose-modified oral chemotherap ...... kin's lymphoma in East Africa.
@nl
type
label
Dose-modified oral chemotherap ...... kin's lymphoma in East Africa.
@en
Dose-modified oral chemotherap ...... kin's lymphoma in East Africa.
@nl
prefLabel
Dose-modified oral chemotherap ...... kin's lymphoma in East Africa.
@en
Dose-modified oral chemotherap ...... kin's lymphoma in East Africa.
@nl
P2093
P2860
P921
P356
P1476
Dose-modified oral chemotherap ...... gkin's lymphoma in East Africa
@en
P2093
Caren Auma Onyango
Cecilia Banura
Christopher C Whalen
Edward Katongole-Mbidde
Fatuma K Abdallah
Henry Wabinga
Howard J Meyerson
Jackson Orem
Jacob Bako
P2860
P304
P356
10.1200/JCO.2008.18.7641
P407
P50
P577
2009-05-26T00:00:00Z